Herbalife (HLF) Exceeds FTC Threshold, Updates Guidance

 | Jun 04, 2017 09:08PM ET

Herbalife Ltd. (NYSE:HLF) informed that 90% of the U.S. sales were documented purchases by consumers in May, which consisted of over three million receipted retail transactions because of its distributors’ commitment. Further, management said it outpaced the key threshold of 80% under its agreement with the U.S. Federal Trade Commission.

Notably, Herbalife recognizes its distributors’ significant efforts and informed that roughly 400,000 customers have converted or signed up as preferred members in the U.S. since Oct 2016.

As a result, the company raised its earnings guidance for the second quarter and full-year 2017. Herbalife now expects its adjusted earnings in the band of 95 cents–$1.15 for the second quarter that ends on Jun 30. Earlier, it had projected the same in the range of 85 cents–$1.05 and delivered $1.29 in the year-ago quarter. The Zacks Consensus Estimate is currently pegged within the company’s guided range at $1.00. In addition, management anticipates earnings per share in the range of 75–95 cents for the quarter versus 65–85 cents guided earlier.

For 2017, Herbalife estimates its adjusted earnings in the band of $4.10–$4.50 per share versus $4.05–$4.45 guided previously. However, the company delivered posted adjusted earnings of $4.85 in 2016. The Zacks Consensus Estimate is currently pegged at the higher end of the current guided range. Moreover, management anticipates earnings per share for the full year in the range of $3.30–$3.70 compared with the previously guided range of $3.25–$3.65.

However, the company expects sales decline to widen in the range of 2–6% from 0.5–4.5%. Also, volumes are expected to decrease 4–8% compared with previous range of 1–5% for the second quarter.

The company expects net sales in 2017 to increase nearly 0.5–3.5% versus 3–6% anticipated earlier. Volumes are projected to be down 1% to up 2% compared with previous guided range of 2–5% growth.

Herbalife issued soft sales guidance for both the second quarter and 2017, due to the new FTC rules in the U.S., softness in its Mexico operations and distributors adopting the latest protocols. Nevertheless, the company believes that its sales will be impacted only for a short time span, which will be followed by a sequential improvement.

Recently, the company posted better-than-expected first-quarter 2017 results. In fact, Herbalife’s earnings have outpaced the Zacks Consensus Estimate for 10 straight quarters now, with a trailing four-quarter average of 18.4%. Also, its shares have outperformed both the Zacks categorized Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes